Cleerly LABS vs DeepRhythmAI

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Cleerly
VS
by Medicalgorithmics

AI Verdict

Cleerly LABS focuses on the structural assessment of coronary arteries using CCTA imaging to detect and characterize atherosclerosis and stenosis. In contrast, DeepRhythmAI specializes in the functional analysis of the heart's electrical activity, detecting and classifying cardiac arrhythmias from ECG data. While both are FDA-cleared cardiology AI tools, they address distinct diagnostic needs within heart health.

Choose Cleerly LABS if…

Choose Cleerly LABS if your primary goal is to precisely detect, quantify, and characterize coronary atherosclerosis and stenosis using CCTA. This tool is ideal for clinicians focused on personalized heart disease management, risk assessment based on plaque burden, and tracking the progression or regression of coronary artery disease over time.

View Cleerly LABS →

Choose DeepRhythmAI if…

Choose DeepRhythmAI if your focus is on highly accurate and efficient detection and classification of cardiac arrhythmias from ECG data. This solution is best suited for healthcare providers seeking to streamline ECG reporting, reduce missed diagnoses of rhythm disorders, and improve clinical workflows related to arrhythmia management.

View DeepRhythmAI →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Cleerly LABS DeepRhythmAI
Pricing Varies Contact vendor for pricing information
Deployment Cloud, On-premise Cloud-based, hardware-agnostic, SaaS, on-prem, hybrid
BAA Available Yes AI-estimated Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

DeepRhythmAI

DeepRhythmAI explicitly highlights its ability to streamline clinical workflows by up to 65% and offers an intuitive user interface, emphasizing significant efficiency gains for healthcare professionals. While Cleerly LABS also features a web-based application with UX refinements and 3D visualization, DeepRhythmAI's quantifiable impact on workflow efficiency provides a stronger case for superior usability in a clinical setting.

Clinical Value

DeepRhythmAI

DeepRhythmAI demonstrates a remarkable and quantifiable clinical impact by reducing the risk of missed arrhythmia diagnoses by 14 to 114 times compared to traditional analysis, with superior sensitivity for critical arrhythmias proven by the DRAI MARTINI study. Cleerly LABS offers comprehensive plaque assessment and prognostic value for major adverse cardiovascular events, which is highly valuable for personalized preventative care, but DeepRhythmAI's direct and significant improvement in diagnostic accuracy for acute, life-threatening conditions gives it an edge.

Pricing & Value

Cleerly LABS

Cleerly LABS provides transparent pricing per analysis and has secured extensive insurance coverage from major payors, including Medicare, UnitedHealthcare, Cigna, and Aetna, significantly enhancing its accessibility and value proposition. DeepRhythmAI's pricing is listed as 'enterprise' with 'unknown' details, making it impossible to assess its cost-effectiveness or value without further information [JSON, cite: 12].

Enterprise Readiness

DeepRhythmAI

DeepRhythmAI demonstrates robust enterprise readiness with a broader array of compliance certifications, including HIPAA, GDPR, HITECH, SOC 2, and ISO 27001, and explicitly offers Business Associate Agreements (BAA). Its device-agnostic integration capabilities and established global customer base since 2005 suggest a highly mature and adaptable solution for various healthcare systems [JSON, cite: 2, 3, 12]. Cleerly LABS also offers strong enterprise features, including HIPAA compliance and EHR integration, but DeepRhythmAI's wider range of certifications and longer global presence provide a slight advantage [JSON, cite: 26].

Innovation

DeepRhythmAI

DeepRhythmAI showcases a high degree of technical innovation by leveraging advanced CNN and Transformer models trained on an exceptionally large dataset of over 250 billion annotated heartbeats, representing a significant scale and cutting-edge approach in ECG analysis [JSON, cite: 2]. Cleerly LABS is also innovative in its comprehensive AI-powered CCTA analysis for preventative care and tracking disease progression, aiming to redefine standards of care [JSON, cite: 8, 9, 17]. However, the sheer scale of data and the use of advanced AI architectures in DeepRhythmAI give it a slight lead in technical innovation.

Support & Docs

Cleerly LABS

Cleerly LABS offers clear and transparent support, including specified operating hours (M-F, 10 am-6 pm ET) and dedicated client support channels for existing users, along with a comprehensive suite of online resources like billing guidelines, publications, and FAQs. DeepRhythmAI mentions general contact options and product information but lacks specific details on support availability or dedicated client support resources, making Cleerly LABS's offerings more robust and accessible.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Cleerly LABS DeepRhythmAI
Name Cleerly LABS DeepRhythmAI
Company Cleerly Medicalgorithmics S.A.
Description AI-powered, FDA-cleared web-based software for comprehensive analysis of coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis, aiding in personalized heart disease management. FDA-cleared, cloud-based AI algorithm that revolutionizes cardiac arrhythmia detection and classification from ECG data, offering superior accuracy and efficiency for physicians.
Primary Use Case Comprehensive coronary plaque assessment and stenosis detection from CCTA. Cardiac arrhythmia detection and classification from ECG data.
Key Features (Examples) AI-powered CCTA image analysis, Comprehensive coronary plaque assessment (volume, type), Stenosis detection and quantification, Ischemia detection (with Cleerly ISCHEMIA module), 3D visualization of coronary arteries, Personalized heart disease risk assessment, Tracking disease progression over time, Integration with PACS, RIS, EHR via Cleerly Proxy AI-powered arrhythmia detection and classification, Utilizes CNN and Transformer models, Trained on 250 billion+ annotated heartbeats, Device-agnostic and integrates with various ECG devices, Cloud-based software, Faster ECG reporting and analysis, Reduces missed diagnoses (14x to 114x fewer), Streamlines clinical workflows (up to 65% efficiency increase)
Categories Cardiology AI, Radiology & Imaging AI Cardiology AI, Clinical Decision Support & Reference
Specialties Cardiology, Radiology Cardiology

Videos

Demos, reviews, and walkthroughs featuring Cleerly LABS and DeepRhythmAI.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Cleerly LABS is designed for comprehensive analysis of coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis, aiding in personalized heart disease management. DeepRhythmAI, conversely, revolutionizes cardiac arrhythmia detection and classification from ECG data, offering superior accuracy and efficiency for physicians.
Cleerly LABS provides comprehensive coronary plaque assessment (volume, type), stenosis detection and quantification, ischemia detection (with its ISCHEMIA module), and 3D visualization of coronary arteries for personalized risk assessment and tracking disease progression. DeepRhythmAI focuses on AI-powered arrhythmia detection and classification, aiming for faster ECG reporting and analysis while significantly reducing missed diagnoses.
Cleerly LABS utilizes AI-powered CCTA image analysis to characterize atherosclerosis and stenosis. DeepRhythmAI employs an AI algorithm that leverages CNN and Transformer models, trained on over 250 billion annotated heartbeats, for its arrhythmia detection and classification.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.